Moderna COVID-19 Vaccine 94.5% Effective In Second Breakthrough
Morderna, a biotech company said on Monday that their early analysis from its Phase 3 trial has shown results of the vaccine’s efficacy to be as high as 94.5% at…
Morderna, a biotech company said on Monday that their early analysis from its Phase 3 trial has shown results of the vaccine’s efficacy to be as high as 94.5% at…
KUALA LUMPUR, Nov 17 — The Ministry of Health (MOH) has announced changes to the National Immunisation Schedule for Children which is being implemented in stages beginning early this month. Health…
For most people in this whole wide world, doing pushups is one of the hardest activities to be done when working out. This activity also feels worse when someone who…
A study of Marine recruits found that despite the temperature check, a preventive measure that is implemented in public places and stores could still lead to the spread of the…
From genes, hormones to the environment, everything can affect the production of oil in the skin. But, did you know diet can also affect the skin? Improper diet choices can…
NUR-SULTAN, Nov 16 — 9,162 people, including 458 children, continue to receive treatment for the coronavirus infection in Kazakhstan, reported the country’s national news agency, KAZINFORM. According to the Ministry of…
SYDNEY, Nov. 13 — An Australian Institute for Infectious Disease will be established in Melbourne, the country’s second largest city and center for biomedical research and manufacturing, China’s Xinhua news…
For those who do not know, November 12th of each year is the date for World Pneumonia Day. Did you all know that pneumonia is the leading cause of death…
Some people feel cute with plump cheeks and some feel unattractive. Most women in particular do not like plump cheeks. Having plump cheeks is like a “fat person” even though…
Monday, The U.S Food and Drug Administration had issued an emergency use authorization for Eli Lilly And Co’s monoclonal antibody therapy to help treat mild to moderate coronavirus cases in…